RealFeedApp betaTop science & technology news, October 26, 2026
- vLLM 0.31 ensures 100% tool call schema accuracy
The new constrained decoding feature guarantees schema adherence, eliminating failures in agentic workloads.
- Resolution autoformalized singularity resolution
Startup Resolution automatically formalized a mathematical statement regarding the resolution of singularities using agents to develop plans. This lays the groundwork for automated research into the relationship between loss landscape geometry and generalization.
- Rapid destabilization is now a diagnosis rather than a warning
A new report diagnoses the climate crisis as currently accelerating, noting that rapid destabilization is now a reality rather than a future warning. Researchers emphasize that stabilizing the climate system depends on drastic cuts in greenhouse gas emissions and ecosystem protection.
- GPT-6.1 Terra delivers faster computer use and better cost efficiency
The new GPT-6.1 Terra model features faster visual reasoning and precise computer use, with standard API pricing reduced by 50% compared to GPT-5.6 Terra and GPT-6.1 Sol to enable high-volume task automation.
- Beacon launches EEG-enabled home sleep testing in 2027
The acquisition doubles Beacon's patient reach and enables EEG-enabled home sleep testing in primary care, telehealth, and psychiatry starting in 2027. Snap operates as a Medicare-registered Independent Diagnostic Testing Facility accredited by The Joint Commission, billing insurers directly.
- New melanoma vaccine outperforms scientists' expectations
A phase 3 clinical trial confirmed the efficacy of the world's first personalized mRNA vaccine against melanoma. Results presented at the 2026 European Society for Medical Oncology Congress and set for publication in the New England Journal of Medicine exceed researchers' expectations.
- Psilocybin forms stable dendritic spines within 24 hours
Research found psilocybin triggers rapid growth of dendritic spines within 24 hours, transforming them from fragile to stable structures. The structural neuroplasticity mechanism operates independently of hallucinogenic effects.
- Stalwart delivers email performance proven by numbers
The team built a completely new mail server that handles millions of emails per second and requires no database migration during upgrades.
- 1.1B LLM pretraining achieved on 6GB VRAM
The researcher independently pre-trained a 1.1 billion parameter model on a laptop with 6GB of VRAM, overcoming limitations cited by other sources.
- New protein molecules reduce toxicity
Researchers are developing novel molecule classes, including ADCs and multispecific antibodies, which promise better selectivity and lower tissue damage compared to existing treatments.
- Moderna CEO expects FDA approval in 2027
Successful intismeran trial results confirm mRNA potential in oncology. The company plans to continue research in rare diseases and autoimmune disorders.
- Modera presents Phase 3 trial results for melanoma vaccine
CEO Stéphane Bancel announced that the custom mRNA therapy intismeran successfully improved patient outcomes in Phase 3 trials, with results set to be presented at the European Society for Medical Oncology annual meeting.
- Received $260 million
Helion and CFS received $260 million in awards but must provide non-voting shares to the government. This marks the first time a federal agency has actively funded the fusion energy sector.
- Bedrock Robotics raises $600 million in funding round
Bedrock Robotics secured $600 million in a Series C round, achieving a $4.1 billion valuation for its self-driving excavator technology. The autonomous system is now deployed on active construction sites in Nevada, Texas, and the US.
- gSWITCH pinpointed key switch genes in OPCs
Researchers used the computational pipeline gSWITCH to identify switch genes with reduced expression in aged cells and found that the transcription factor Bcl11a regulates them.
- CNYX-005 boosts sleep in older animals
The oral candidate CNYX-005 increased NREM sleep duration in aged rats. Carnyx Therapeutics hired Chris Brearley as chief medical officer.
- RynnUnify employs a 16B unified embodied model architecture
Researchers released a 16B model capable of long-horizon visual planning and robot control via interleaved video-language reasoning and reinforcement learning.
- 17 coding-agent systems perform worse under shifted conditions
The SWE-Shift benchmark demonstrates that 17 coding-agent systems perform significantly worse when tasks or dependencies change mid-execution. GPT-6 Astra's success rate dropped from 67.35% to 24.79% as it struggled to preserve valid work during state updates.
- Gram released editor version 3.4.0
The release addresses a critical vulnerability caused by shipping outdated webpki-roots packages. New features include a side-by-side Git diff view and other improvements.
- Five silicon qubits operated with 99.9% accuracy
A new technique enables simultaneous control of five silicon qubits with approximately 99.9% accuracy, overcoming the accuracy drop when multiple qubits operate together. This approach facilitates the development of larger quantum processors using standard semiconductor manufacturing.
